| Symbol |
Name |
|
A2ML1
|
alpha-2-macroglobulin-like 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACTB
|
actin, beta
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
ALB
|
albumin
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ANXA5
|
annexin A5
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
ARHGAP24
|
Rho GTPase activating protein 24
|
|
ARHGEF1
|
Rho guanine nucleotide exchange factor (GEF) 1
|
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
|
ASRGL1
|
asparaginase like 1
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP5E
|
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit
|
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2
|
|
BAX
|
BCL2-associated X protein
|
|
BCAT1
|
branched chain amino-acid transaminase 1, cytosolic
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BCS1L
|
BC1 (ubiquinol-cytochrome c reductase) synthesis-like
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BRAP
|
BRCA1 associated protein
|
|
BSPH1
|
binder of sperm protein homolog 1
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALR
|
calreticulin
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCNA1
|
cyclin A1
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD14
|
CD14 molecule
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CD9
|
CD9 molecule
|
|
CDCA7
|
cell division cycle associated 7
|
|
CDCP1
|
CUB domain containing protein 1
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
|
CFC1
|
cripto, FRL-1, cryptic family 1
|
|
CHAF1A
|
chromatin assembly factor 1, subunit A (p150)
|
|
CIB1
|
calcium and integrin binding 1 (calmyrin)
|
|
CIP2A
|
cellular inhibitor of PP2A
|
|
CNTNAP1
|
contactin associated protein 1
|
|
COBLL1
|
cordon-bleu WH2 repeat protein-like 1
|
|
CREBBP
|
CREB binding protein
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTR9
|
CTR9, Paf1/RNA polymerase II complex component
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DCC
|
DCC netrin 1 receptor
|
|
DDX43
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 43
|
|
DLL1
|
delta-like 1 (Drosophila)
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DNTT
|
DNA nucleotidylexotransferase
|
|
E2F1
|
E2F transcription factor 1
|
|
EBF2
|
early B-cell factor 2
|
|
EDNRB
|
endothelin receptor type B
|
|
EIF3A
|
eukaryotic translation initiation factor 3, subunit A
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
ELN
|
elastin
|
|
ELP1
|
elongator acetyltransferase complex subunit 1
|
|
EN2
|
engrailed homeobox 2
|
|
ENPEP
|
glutamyl aminopeptidase (aminopeptidase A)
|
|
EP300
|
E1A binding protein p300
|
|
EPHB4
|
EPH receptor B4
|
|
EPO
|
erythropoietin
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESPL1
|
extra spindle pole bodies homolog 1 (S. cerevisiae)
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
ETV6
|
ets variant 6
|
|
EVPL
|
envoplakin
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
FANCB
|
Fanconi anemia, complementation group B
|
|
FAS
|
Fas cell surface death receptor
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FHIT
|
fragile histidine triad
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXO3
|
forkhead box O3
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
FUT1
|
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group)
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GFI1B
|
growth factor independent 1B transcription repressor
|
|
GNL3
|
guanine nucleotide binding protein-like 3 (nucleolar)
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTK1
|
glutathione S-transferase kappa 1
|
|
GYPA
|
glycophorin A (MNS blood group)
|
|
GYPB
|
glycophorin B (MNS blood group)
|
|
GYPE
|
glycophorin E (MNS blood group)
|
|
H2AX
|
H2A.X variant histone
|
|
H2BFS
|
H2B histone family, member S (pseudogene)
|
|
HDAC1
|
histone deacetylase 1
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HMOX1
|
heme oxygenase 1
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HOXA4
|
homeobox A4
|
|
HOXA5
|
homeobox A5
|
|
HOXA9
|
homeobox A9
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA13
|
interferon, alpha 13
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGH
|
immunoglobulin heavy locus
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
IMMT
|
inner membrane protein, mitochondrial
|
|
IMPA1
|
inositol(myo)-1(or 4)-monophosphatase 1
|
|
IRF8
|
interferon regulatory factor 8
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
JAK2
|
Janus kinase 2
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LBR
|
lamin B receptor
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEPR
|
leptin receptor
|
|
LHX4
|
LIM homeobox 4
|
|
LIF
|
leukemia inhibitory factor
|
|
LOC102724334
|
histone H2B type F-S-like
|
|
LTB4R2
|
leukotriene B4 receptor 2
|
|
LYZ
|
lysozyme
|
|
MAD1L1
|
MAD1 mitotic arrest deficient-like 1 (yeast)
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MARCKSL1
|
MARCKS-like 1
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MBNL3
|
muscleblind-like splicing regulator 3
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPO
|
myeloperoxidase
|
|
MPP1
|
membrane protein, palmitoylated 1, 55kDa
|
|
MRPL28
|
mitochondrial ribosomal protein L28
|
|
MSH3
|
mutS homolog 3
|
|
MSI2
|
musashi RNA-binding protein 2
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NUDCD1
|
NudC domain containing 1
|
|
NUP98
|
nucleoporin 98kDa
|
|
NXT1
|
nuclear transport factor 2-like export factor 1
|
|
OPN1SW
|
opsin 1 (cone pigments), short-wave-sensitive
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
P4HB
|
prolyl 4-hydroxylase, beta polypeptide
|
|
PACRG
|
PARK2 co-regulated
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PCBP2
|
poly(rC) binding protein 2
|
|
PCNT
|
pericentrin
|
|
PCYT1A
|
phosphate cytidylyltransferase 1, choline, alpha
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PEG10
|
paternally expressed 10
|
|
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
|
|
PIK3R4
|
phosphoinositide-3-kinase, regulatory subunit 4
|
|
POLG2
|
polymerase (DNA directed), gamma 2, accessory subunit
|
|
POLM
|
polymerase (DNA directed), mu
|
|
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PROM1
|
prominin 1
|
|
PSMB6
|
proteasome (prosome, macropain) subunit, beta type, 6
|
|
PSMD12
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 12
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTPA
|
protein phosphatase 2 phosphatase activator
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
RAB3GAP2
|
RAB3 GTPase activating protein subunit 2 (non-catalytic)
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RALGAPB
|
Ral GTPase activating protein, beta subunit (non-catalytic)
|
|
RBM45
|
RNA binding motif protein 45
|
|
RBP2
|
retinol binding protein 2, cellular
|
|
RHOA
|
ras homolog family member A
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RPL22
|
ribosomal protein L22
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RREB1
|
ras responsive element binding protein 1
|
|
RTL1
|
retrotransposon-like 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
SCT
|
secretin
|
|
SET
|
SET nuclear proto-oncogene
|
|
SETMAR
|
SET domain and mariner transposase fusion gene
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFTPA1
|
surfactant protein A1
|
|
SGSM3
|
small G protein signaling modulator 3
|
|
SH2B3
|
SH2B adaptor protein 3
|
|
SIPA1
|
signal-induced proliferation-associated 1
|
|
SLC25A1
|
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1
|
|
SLC25A3
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3
|
|
SLCO6A1
|
solute carrier organic anion transporter family, member 6A1
|
|
SMAD1
|
SMAD family member 1
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
SUB1
|
SUB1 homolog (S. cerevisiae)
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
TBC1D9
|
TBC1 domain family, member 9 (with GRAM domain)
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TKTL1
|
transketolase-like 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
UNG
|
uracil-DNA glycosylase
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VPREB1
|
pre-B lymphocyte 1
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WLS
|
wntless Wnt ligand secretion mediator
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT3
|
wingless-type MMTV integration site family, member 3
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WT1
|
Wilms tumor 1
|
|
YY1
|
YY1 transcription factor
|
|
ZCCHC16
|
zinc finger, CCHC domain containing 16
|
|
ZCCHC5
|
zinc finger, CCHC domain containing 5
|
|
ZHX2
|
zinc fingers and homeoboxes 2
|
|
ZNF423
|
zinc finger protein 423
|
